Insider Shareholders with Direct Ownership of Adverum Biotechnologies, Inc. (ADVM)
This section provides a comprehensive overview of the insiders with direct ownership of Adverum Biotechnologies, Inc. (ADVM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Adverum Biotechnologies, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Laurent Fischer
CEO, PRESIDENT AND DIRECTOR |
748,600 | 82,321 | 692,141 $3.38 Million | 8 |
Mar 15, 2023
Reduced 5.62%
|
|
Peter Soparkar
CHIEF OPERATING OFFICER |
266,925 | 26,665 | 265,891 $1.3 Million | 5 |
Mar 15, 2023
Reduced 4.78%
|
|
Julie Clark
Chief Medical Officer |
120,000 | 4,766 | 164,723 $805,495 | 2 |
Sep 30, 2021
Reduced 2.81%
|
|
Angela Thedinga
Chief Technology Officer |
150,000 | 0 | 150,000 $733,500 | 1 |
Aug 06, 2021
Added 50.0%
|
| 130,000 | 0 | 130,000 $635,700 | 1 |
Feb 07, 2024
Added 50.0%
|
|
|
Brigit Riley
Chief Scientific Officer |
0 | 14,565 | 117,435 $574,257 | 2 |
Mar 15, 2023
Reduced 5.85%
|
|
Linda M Rubinstein
CHIEF FINANCIAL OFFICER |
100,000 | 0 | 100,000 $488,999 | 1 |
Jun 07, 2023
Added 50.0%
|
| 100,000 | 0 | 100,000 $488,999 | 1 |
Feb 07, 2024
Added 50.0%
|
|
|
Leone D Patterson
President and CFO |
0 | 12,533 | 97,955 $478,999 | 1 |
Feb 09, 2021
Reduced 0.06%
|
| 20,000 | 0 | 88,182 $431,209 | 2 |
Mar 24, 2021
Added 10.19%
|
|
| 50,000 | 0 | 50,000 $244,499 | 2 |
May 16, 2022
Added 37.5%
|
|
|
Setareh Seyedkazemi
CHIEF DEVELOPMENT OFFICER |
53,333 | 12,259 | 47,674 $233,125 | 4 |
Sep 15, 2023
Reduced 0.27%
|
|
Richard Beckman
Chief Medical Officer |
35,000 | 4,272 | 39,061 $191,008 | 3 |
Sep 19, 2022
Reduced 9.86%
|
|
Rupert D'Souza
Chief Financial Officer |
20,000 | 0 | 20,850 $101,956 | 2 |
May 17, 2022
Added 32.41%
|
|
Thomas Woiwode
Director |
12,783 | 0 | 18,822 $92,039 | 1 |
Dec 14, 2020
Added 40.45%
|